Corrigendum: Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab (Annals of Oncology (2017) 28:6 (1368-1379) DOI: 10.1093/annonc/mdx108)

N. Chaput; P. Lepage; C. Coutzac; E. Soularue; K. Le Roux; C. Monot; L. Boselli; E. Routier; L. Cassard; M. Collins; T. Vaysse; L. Marthey; A. Eggermont; V. Asvatourian; E. Lanoy; C. Mateus; C. Robert; F. Carbonnel

doi:10.1093/annonc/mdz224

Corrigendum: Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab (Annals of Oncology (2017) 28:6 (1368-1379) DOI: 10.1093/annonc/mdx108)

N. Chaput, P. Lepage, C. Coutzac, E. Soularue, K. Le Roux, C. Monot, L. Boselli, E. Routier, L. Cassard, M. Collins, T. Vaysse, L. Marthey, A. Eggermont, V. Asvatourian, E. Lanoy, C. Mateus, C. Robert, F. Carbonnel

Research related

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

68 Citaten (Scopus)

Samenvatting

In the original article, there were errors in Figure 3B and the accompanying legend. These have been corrected online as below.

Originele taal-2	Engels
Pagina's (van-tot)	2012
Aantal pagina's	1
Tijdschrift	Annals of Oncology
Volume	30
Nummer van het tijdschrift	12
DOI's	https://doi.org/10.1093/annonc/mdz224
Status	Gepubliceerd - 1 dec. 2019

Toegang tot document

10.1093/annonc/mdz224

Vingerafdruk

Duik in de onderzoeksthema's van 'Corrigendum: Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab (Annals of Oncology (2017) 28:6 (1368-1379) DOI: 10.1093/annonc/mdx108)'. Samen vormen ze een unieke vingerafdruk.

Citeer dit

Chaput, N., Lepage, P., Coutzac, C., Soularue, E., Le Roux, K., Monot, C., Boselli, L., Routier, E., Cassard, L., Collins, M., Vaysse, T., Marthey, L., Eggermont, A., Asvatourian, V., Lanoy, E., Mateus, C., Robert, C., & Carbonnel, F. (2019). Corrigendum: Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab (Annals of Oncology (2017) 28:6 (1368-1379) DOI: 10.1093/annonc/mdx108). Annals of Oncology, 30(12), 2012. https://doi.org/10.1093/annonc/mdz224

@article{a9a0db7c2443479abc42412cae229755,

title = "Corrigendum: Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab (Annals of Oncology (2017) 28:6 (1368-1379) DOI: 10.1093/annonc/mdx108)",

abstract = "In the original article, there were errors in Figure 3B and the accompanying legend. These have been corrected online as below.",

author = "N. Chaput and P. Lepage and C. Coutzac and E. Soularue and {Le Roux}, K. and C. Monot and L. Boselli and E. Routier and L. Cassard and M. Collins and T. Vaysse and L. Marthey and A. Eggermont and V. Asvatourian and E. Lanoy and C. Mateus and C. Robert and F. Carbonnel",

year = "2019",

month = dec,

day = "1",

doi = "10.1093/annonc/mdz224",

language = "English",

volume = "30",

pages = "2012",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "12",

}

Chaput, N, Lepage, P, Coutzac, C, Soularue, E, Le Roux, K, Monot, C, Boselli, L, Routier, E, Cassard, L, Collins, M, Vaysse, T, Marthey, L, Eggermont, A, Asvatourian, V, Lanoy, E, Mateus, C, Robert, C & Carbonnel, F 2019, 'Corrigendum: Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab (Annals of Oncology (2017) 28:6 (1368-1379) DOI: 10.1093/annonc/mdx108)', Annals of Oncology, vol. 30, nr. 12, blz. 2012. https://doi.org/10.1093/annonc/mdz224

Corrigendum: Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab (Annals of Oncology (2017) 28:6 (1368-1379) DOI: 10.1093/annonc/mdx108). / Chaput, N.; Lepage, P.; Coutzac, C. et al.
In: Annals of Oncology, Vol. 30, Nr. 12, 01.12.2019, blz. 2012.

Onderzoeksoutput: Bijdrage aan tijdschrift › Opmerking/debat

TY - JOUR

T1 - Corrigendum

T2 - Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab (Annals of Oncology (2017) 28:6 (1368-1379) DOI: 10.1093/annonc/mdx108)

AU - Chaput, N.

AU - Lepage, P.

AU - Coutzac, C.

AU - Soularue, E.

AU - Le Roux, K.

AU - Monot, C.

AU - Boselli, L.

AU - Routier, E.

AU - Cassard, L.

AU - Collins, M.

AU - Vaysse, T.

AU - Marthey, L.

AU - Eggermont, A.

AU - Asvatourian, V.

AU - Lanoy, E.

AU - Mateus, C.

AU - Robert, C.

AU - Carbonnel, F.

PY - 2019/12/1

Y1 - 2019/12/1

N2 - In the original article, there were errors in Figure 3B and the accompanying legend. These have been corrected online as below.

AB - In the original article, there were errors in Figure 3B and the accompanying legend. These have been corrected online as below.

UR - http://www.scopus.com/inward/record.url?scp=85077403715&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdz224

DO - 10.1093/annonc/mdz224

M3 - Comment/debate

C2 - 31408090

AN - SCOPUS:85077403715

SN - 0923-7534

VL - 30

SP - 2012

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -